TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25974830

Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 73

Group type: COMPARATOR
Intervention: Traditional scalpel with electric knife (Control)
Number of subjects: 73
Study: 23369444

Group type: EXPERIMENTAL
Intervention: Bone-tendon Achilles allograft (group I)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Free tendon Achilles allograft (group II)
Number of subjects: 72
Study: 20526626

Group type: EXPERIMENTAL
Intervention: Single-site laparoscopic appendectomy (SSLA)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional laparoscopic appendectomy (CLA)
Number of subjects: 43
Study: 19144985

Group type: EXPERIMENTAL
Intervention: R-CHOP-14 (Rituximab with CHOP-14)
Number of subjects: 1222

Group type: COMPARATOR
Intervention: CHOP-14
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: R-CHOP-14
Number of subjects: 1222

Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate
Number of subjects: 1222
Study: 17708384

Group type: EXPERIMENTAL
Intervention: Honey dressings
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sugar dressings
Number of subjects: 40
Study: 14982719

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Psychosocial activity
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Interaction between physical and psychosocial activity
Number of subjects: 171
Study: 11480800

Group type: EXPERIMENTAL
Intervention: Foils selected based on their match to the perpetrator in perp-absent lineups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Foils selected based on their match to the innocent suspect in perp-absent lineups
Number of subjects: 0
Study: 9972071

Group type: EXPERIMENTAL
Intervention: Children with neurological disorders (mean blood lead levels 19.30 +/- 17.65 micrograms/dl)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control children (mean blood lead levels 11.96 +/- 10.97 micrograms/dl)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Children with pica behaviour
Number of subjects: 82
Study: 7735156

Group type: EXPERIMENTAL
Intervention: Low stimulus levels (L1 = 55, L2 = 40 dB SPL) in healthy term infants
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low stimulus levels (L1 = 55, L2 = 40 dB SPL) in healthy adults
Number of subjects: 50
Study: 3189422

Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 31327203

Group type: EXPERIMENTAL
Intervention: In vitro cultured Calculus Bovis
Number of subjects: 80
Study: 30341276

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behaviour therapy (CBT) for anxiety disorders, 4 weekly sessions
Number of subjects: 28

Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behaviour therapy (CBT)
Number of subjects: 28
Study: 27875537

Group type: EXPERIMENTAL
Intervention: L-tryptophan (0.52 g and 1.56 g)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: L-tryptophan (1.56 g)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: L-tryptophan and L-leucine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (75 g glucose and 300 mL tap water)
Number of subjects: 20
Study: 25005196

Group type: EXPERIMENTAL
Intervention: Modified PCIOL implantation with transscleral fixation (39.95 ± 5.87 min)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional PCIOL implantation in the ciliary sulcus (45.77 ± 5.21 min)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups (modified and conventional)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 82
Study: 23258283

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 20369718

Group type: EXPERIMENTAL
Intervention: dichlorobis (N1‐dichloromethyl‐3,5‐dimethylpyrazole, copper (II) compound
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no treatment with the copper (II) compound)
Number of subjects: 25
Study: 17395047

Group type: EXPERIMENTAL
Intervention: Candesartan (titrated to 32 mg once per day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 15620485

Group type: EXPERIMENTAL
Intervention: Avanta implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: Swanson implants
Number of subjects: 30
Study: 11832876

Group type: EXPERIMENTAL
Intervention: Gymnasts
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 12
Study: 10100393

Group type: EXPERIMENTAL
Intervention: Attentional selection based on spatial frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procedural differences in studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contrast balancing
Number of subjects: 0
Study: 8585113

Group type: EXPERIMENTAL
Intervention: Monoclonal fluorescence polarization immunoassay (mFPIA) for cyclosporine monitoring in SPK recipients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-performance liquid chromatography (HPLC) for cyclosporine monitoring in SPK recipients
Number of subjects: 12

Group type: COMPARATOR
Intervention: Monoclonal fluorescence polarization immunoassay (mFPIA) for cyclosporine monitoring in kidney-alone recipients
Number of subjects: 12
Study: 2331636

Group type: EXPERIMENTAL
Intervention: Augmented visual feedback on magnitude of force application and cadence
Number of subjects: 6

Group type: COMPARATOR
Intervention: Augmented feedback on pedaling rate
Number of subjects: 6
Study: 375958

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of Atenolol and Chlorthalidone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination therapy vs Placebo
Number of subjects: 15
Study: 31035784

Group type: EXPERIMENTAL
Intervention: Nitrous Oxide (N2O) anesthesia
Number of subjects: 88

Group type: COMPARATOR
Intervention: No Nitrous Oxide anesthesia
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 29329168

Group type: EXPERIMENTAL
Intervention: MenABCWY booster dose
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: 4CMenB
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: MenABCWY and 4CMenB
Number of subjects: 190

Group type: COMPARATOR
Intervention: MenABCWY
Number of subjects: 190
Study: 27749572

Group type: EXPERIMENTAL
Intervention: Prediction model for diabetes using a subdistribution hazards model
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Body mass index, FPG, self‐rated health status, and physical activity
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Poor self‐rated health status
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Less physical activity
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Age 55-65 years
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Prediction model performance
Number of subjects: 1857
Study: 24139668

Group type: EXPERIMENTAL
Intervention: Guided Experiential Learning (GEL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Experiential Learning Theory (ELT)
Number of subjects: 30
Study: 22311059

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 2
Study: 19428117

Group type: EXPERIMENTAL
Intervention: 12 x 90 minute psychoeducation sessions (SIMSEP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: SIMSEP
Number of subjects: 58

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 58
Study: 17599429

Group type: EXPERIMENTAL
Intervention: Intervention strategies from the ACCORD trial
Number of subjects: 4311

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis (CEA)
Number of subjects: 4311

Group type: EXPERIMENTAL
Intervention: Health Utilities Index Mark 3 (HUI-3)
Number of subjects: 4311

Group type: EXPERIMENTAL
Intervention: Direct medical costs
Number of subjects: 4311

Group type: EXPERIMENTAL
Intervention: HRQOL assessments
Number of subjects: 4311
Study: 15958322

Group type: COMPARATOR
Intervention: Conventional radiotherapy (66 to 70 Gy in 33 to 35 fractions over 6 to 7 weeks)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Late course 3DCRT (24-30 Gy in 6 fractions, 400-500 cGy per fraction every other day after 40 Gy conventional radiotherapy, completed in 5 to 6 weeks)
Number of subjects: 86
Study: 11851644

Group type: EXPERIMENTAL
Intervention: L-NMMA (NO synthase inhibitor)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: ANGII
Number of subjects: 8
Study: 11155471

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 18
Study: 8636779

Group type: EXPERIMENTAL
Intervention: GM‐CSF 5 micrograms/kg/d
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: GM‐CSF
Number of subjects: 134
Study: 1583243

Group type: EXPERIMENTAL
Intervention: Antigen challenge
Number of subjects: 6

Group type: COMPARATOR
Intervention: Diluent control
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Correlation with histamine and eosinophil influx
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Correlation with area of late-phase response (LPR)
Number of subjects: 6
Study: 6367882

Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy (routine dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher dosage (more than 1510 ret)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no irradiation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased radiotherapy dosage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irradiation
Number of subjects: 0
Study: 31000783

Group type: EXPERIMENTAL
Intervention: Metabolic gastric bypass
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Greater curvature plication
Number of subjects: 40
Study: 30053018

Group type: EXPERIMENTAL
Intervention: CPE isolates identified from rectal swabs
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Carbapenemase characterization and antibiotic susceptibility testing
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Identification of carbapenemases
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Clonality and diversity assessment
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Emergence of new clones
Number of subjects: 162
Study: 27207971

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 21105

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21105
Study: 24549966

Group type: EXPERIMENTAL
Intervention: Minimally invasive plate osteosynthesis (group A)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Locking intramedullary nail (group B)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: External fixation combined with limited open reduction and absorbable internal fixation (group C)
Number of subjects: 137

Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 137
Study: 21632443

Group type: EXPERIMENTAL
Intervention: NEPP
Number of subjects: 50

Group type: COMPARATOR
Intervention: sPD
Number of subjects: 50
Study: 21084546

Group type: EXPERIMENTAL
Intervention: Hydro Acoustic Therapy (HAT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: flutter valve
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo (sitting in the bath with sounds without vibration)
Number of subjects: 18
Study: 18936373

Group type: EXPERIMENTAL
Intervention: Occlusive dressings (foams, alginates, hydrogels, hydrocolloids, hydrofibers, or films)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Gauze-based dressings
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Occlusive dressings
Number of subjects: 285
Study: 15805860

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (ND before adjuvant therapy)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Radiotherapy alone
Number of subjects: 97
Study: 12532470

Group type: EXPERIMENTAL
Intervention: Short veno-venous hemofiltration (SVVH)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Long veno-venous hemofiltration (LVVH)
Number of subjects: 36
Study: 10756363

Group type: EXPERIMENTAL
Intervention: Aprotinin (high dose)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Aprotinin (pump-prime-only dose)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No aprotinin treatment (control)
Number of subjects: 53
Study: 8882473

Group type: COMPARATOR
Intervention: Supine bicycle exercise (SBE) in healthy controls
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Supine bicycle exercise (SBE) in nephrotic syndrome patients
Number of subjects: 38

Group type: COMPARATOR
Intervention: Comparison of ANP change between controls and nephrotic syndrome patients
Number of subjects: 38
Study: 1645086

Group type: EXPERIMENTAL
Intervention: Low tar, middle nicotine cigarettes
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Middle tar, middle nicotine cigarettes
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Low tar, low nicotine cigarettes
Number of subjects: 643

Group type: COMPARATOR
Intervention: Health warning (control group)
Number of subjects: 643
Study: 31124600

Group type: EXPERIMENTAL
Intervention: Perioperative antibiotic prophylaxis (PAP)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: PAP for immunocompromised patients
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Administration of PAP parenterally
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Cephalosporin cefuroxime
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Duration of PAP
Number of subjects: 78
Study: 29186175

Group type: EXPERIMENTAL
Intervention: Oral vocabulary training program (definition method)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral vocabulary training program (context method)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Read-aloud method (control)
Number of subjects: 100
Study: 26109246

Group type: EXPERIMENTAL
Intervention: High risk ASD group (36-month-olds)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low risk control group (18- and 24-month-olds)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High risk ASD group
Number of subjects: 0
Study: 22576127

Group type: EXPERIMENTAL
Intervention: Condom use during sex acts
Number of subjects: 3257

Group type: EXPERIMENTAL
Intervention: Situational factors related to male clients' behaviors
Number of subjects: 3257

Group type: EXPERIMENTAL
Intervention: Having vaginal and anal sex at the same encounter
Number of subjects: 3257

Group type: EXPERIMENTAL
Intervention: Use of poor-fitting condoms
Number of subjects: 3257

Group type: EXPERIMENTAL
Intervention: High client volume of FSWs
Number of subjects: 3257
Study: 20922772

Group type: EXPERIMENTAL
Intervention: Psycho-educational programme (PEP) for primary caregivers in 12 group sessions for 3 months
Number of subjects: 167

Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 167
Study: 19016711

Group type: EXPERIMENTAL
Intervention: Talarozole (0.35% or 0.07%)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 16
Study: 17723127

Group type: EXPERIMENTAL
Intervention: Nadroparin 2850 antifactor Xa units once daily for 3 weeks
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113

Group type: COMPARATOR
Intervention: Nadroparin and Placebo
Number of subjects: 113
Study: 14739870

Group type: EXPERIMENTAL
Intervention: Cervical spine manipulation
Number of subjects: 336

Group type: COMPARATOR
Intervention: Mobilization
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Adverse reactions (general)
Number of subjects: 336
Study: 11719833

Group type: EXPERIMENTAL
Intervention: High Dose Bay 27‐9955 200 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Low Dose Bay 27‐9955 70 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 9604731

Group type: EXPERIMENTAL
Intervention: Piroxicam-FDDF (40 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Naproxen sodium (550 mg)
Number of subjects: 40
Study: 7798839

Group type: EXPERIMENTAL
Intervention: Total polycythemic infants
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Asymptomatic polycythemic infants
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (twin sibs)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (excluding twin sibs)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Partial plasma exchange transfusion in asymptomatic infants
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Low birthweight and small for gestational age infants
Number of subjects: 68
Study: 2899196

Group type: EXPERIMENTAL
Intervention: Outreach villages (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control villages (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NCDDP promotion of better treatment
Number of subjects: 0
Study: 31221553

Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left DLPFC
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study: 27179290

Group type: EXPERIMENTAL
Intervention: Goal attainment method
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Goal attainment
Number of subjects: 212
Study: 25884717

Group type: EXPERIMENTAL
Intervention: Blended Learning (BL) approach
Number of subjects: 147

Group type: COMPARATOR
Intervention: Didactic Learning (DL) approach
Number of subjects: 147
Study: 23766642

Group type: EXPERIMENTAL
Intervention: Postoperative pelvic floor muscle exercise (PFE) every day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no PFE)
Number of subjects: 66
Study: 21239976

Group type: EXPERIMENTAL
Intervention: TEA (Thoracic Epidural Anesthesia)
Number of subjects: 654

Group type: COMPARATOR
Intervention: GA (General Anesthesia)
Number of subjects: 654
Study: 20166432

Group type: EXPERIMENTAL
Intervention: Cefteram pivoxil (test preparation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Cefteram pivoxil (reference preparation)
Number of subjects: 24
Study: 16770243

Group type: EXPERIMENTAL
Intervention: Basiliximab (BAS)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Muromonab (OKT3)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Basiliximab (BAS) and Muromonab (OKT3)
Number of subjects: 99
Study: 15585778

Group type: EXPERIMENTAL
Intervention: cis‐9,trans‐11 CLA (0.59, 1.19, and 2.38 g/d)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: trans‐10,cis‐12 CLA (0.63, 1.26, and 2.52 g/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 11745270

Group type: EXPERIMENTAL
Intervention: Protocol A: Twice-daily TBI (1.7 Gy for 3 days, total 10.2 Gy)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Protocol B: Once-daily TBI (3 Gy for 4 days, total 12 Gy)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 82
Study: 9011596

Group type: EXPERIMENTAL
Intervention: Epoetin beta (5 x 500 U intravenously over a 14-day period before surgery)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 76
Study: 8238222

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (50 mg/ml for five minutes)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (no intraoperative 5-fluorouracil)
Number of subjects: 55
Study: 3608729

Group type: EXPERIMENTAL
Intervention: Total serum bile acids (TSBA)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Conjugated cholic acid (CCA)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Aspartate aminotransferase
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Sequential aspartate aminotransferase measurement followed by CCA
Number of subjects: 429
Study: 31295625

Group type: EXPERIMENTAL
Intervention: Emotional vocal sound (happy/angry)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional sounds (happy/angry)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Congruent emotional cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control study
Number of subjects: 0
Study: 28222649

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Topical washing with tranexamic acid
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Retrograde tranexamic acid through drain
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no tranexamic acid)
Number of subjects: 50
Study: 24564346

Group type: EXPERIMENTAL
Intervention: Gluten and milk diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23842829

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 21816223

Group type: EXPERIMENTAL
Intervention: Broccoli sprouts (40 g)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Broccoli supplement (6 pills)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Alfalfa sprouts (negative control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo pills (negative control)
Number of subjects: 16
Study: 19378637

Group type: EXPERIMENTAL
Intervention: Awareness of the Tuskegee Syphilis Study (TSS)
Number of subjects: 1162

Group type: COMPARATOR
Intervention: Previous findings from the 1999-2000 4-City TLP Study
Number of subjects: 1162
Study: 17684633

Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 118

Group type: COMPARATOR
Intervention: Tetanus control vaccine
Number of subjects: 118
Study: 16087026

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 100
Study: 12074614

Group type: EXPERIMENTAL
Intervention: Hyaluronidase injection and aspiration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgical excision
Number of subjects: 50